This Is Breakthrough: Dr. Dan Pollyea
See how Pollyea's team is transforming the treatment of acute myeloid leukemia (AML), one of the most aggressive blood cancers
Apr 2, 2020
Categories:
Division of Hematology
|
Tags:
2020
patient care
research
